152
RMDA: The Pharma Growth Engine 💊🚀

The Driver: High-margin growth in chronic treatments.
Revenue hit EGP 3.95B with steady institutional backing. 📈💰

Sharia Status: ✅ Compliant. A stable member of the EGX33 Shariah Index. ☪️📜

The Valuation: Trades at a premium P/E (~21x), reflecting its faster expansion vs. peers. 💎📊

The Technicals:
the 3.79 EGP level (61.8% Fibonacci). This is the last line of defense for the medium-term bullish structure. 📏🛡️
If 3.79 fails, the price is likely headed for a "Mean Reversion" at the 200-day Moving Average (at 3.4). 🧲📉


The Risk: Vulnerable to API import costs and currency-driven margin squeezes. ⚠️🏗️


If you like my posts, please follow and boost 🙌

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.